Two Point Mutations in the Glycoprotein of SFTSV Enhance the Propagation Recombinant Vesicular Stomatitis Virus Vectors at Assembly Step

Severe fever with thrombocytopenia syndrome virus (SFTSV) is an emerging tick-borne pathogen for which approved therapeutic drugs or vaccines are not available. We previously developed a recombinant vesicular stomatitis virus-based vaccine candidate (rVSV-SFTSV) by replacing the original glycoprotei...

Full description

Bibliographic Details
Main Authors: Qiang Hu, Yuhang Zhang, Jiafu Jiang, Aihua Zheng
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/15/3/800
_version_ 1797608637335601152
author Qiang Hu
Yuhang Zhang
Jiafu Jiang
Aihua Zheng
author_facet Qiang Hu
Yuhang Zhang
Jiafu Jiang
Aihua Zheng
author_sort Qiang Hu
collection DOAJ
description Severe fever with thrombocytopenia syndrome virus (SFTSV) is an emerging tick-borne pathogen for which approved therapeutic drugs or vaccines are not available. We previously developed a recombinant vesicular stomatitis virus-based vaccine candidate (rVSV-SFTSV) by replacing the original glycoprotein with Gn/Gc from SFTSV, which conferred complete protection in a mouse model. Here, we found that two spontaneous mutations, M749T/C617R, emerged in the Gc glycoprotein during passaging that could significantly increase the titer of rVSV-SFTSV. M749T/C617R enhanced the genetic stability of rVSV-SFTSV, and no further mutations appeared after 10 passages. Using immunofluorescence analysis, we found that M749T/C617R could increase glycoprotein traffic to the plasma membrane, thus facilitating virus assembly. Remarkably, the broad-spectrum immunogenicity of rVSV-SFTSV was not affected by the M749T/C617R mutations. Overall, M749T/C617R could enhance the further development of rVSV-SFTSV into an effective vaccine in the future.
first_indexed 2024-03-11T05:46:00Z
format Article
id doaj.art-a338628da6ce48dd9ed454e21a1a5860
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-11T05:46:00Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-a338628da6ce48dd9ed454e21a1a58602023-11-17T14:24:31ZengMDPI AGViruses1999-49152023-03-0115380010.3390/v15030800Two Point Mutations in the Glycoprotein of SFTSV Enhance the Propagation Recombinant Vesicular Stomatitis Virus Vectors at Assembly StepQiang Hu0Yuhang Zhang1Jiafu Jiang2Aihua Zheng3College of Life Science, Hebei University, Baoding 071002, ChinaState Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, ChinaState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, ChinaState Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, ChinaSevere fever with thrombocytopenia syndrome virus (SFTSV) is an emerging tick-borne pathogen for which approved therapeutic drugs or vaccines are not available. We previously developed a recombinant vesicular stomatitis virus-based vaccine candidate (rVSV-SFTSV) by replacing the original glycoprotein with Gn/Gc from SFTSV, which conferred complete protection in a mouse model. Here, we found that two spontaneous mutations, M749T/C617R, emerged in the Gc glycoprotein during passaging that could significantly increase the titer of rVSV-SFTSV. M749T/C617R enhanced the genetic stability of rVSV-SFTSV, and no further mutations appeared after 10 passages. Using immunofluorescence analysis, we found that M749T/C617R could increase glycoprotein traffic to the plasma membrane, thus facilitating virus assembly. Remarkably, the broad-spectrum immunogenicity of rVSV-SFTSV was not affected by the M749T/C617R mutations. Overall, M749T/C617R could enhance the further development of rVSV-SFTSV into an effective vaccine in the future.https://www.mdpi.com/1999-4915/15/3/800SFTSVvaccinevesicular stomatitis virusmutationassembly
spellingShingle Qiang Hu
Yuhang Zhang
Jiafu Jiang
Aihua Zheng
Two Point Mutations in the Glycoprotein of SFTSV Enhance the Propagation Recombinant Vesicular Stomatitis Virus Vectors at Assembly Step
Viruses
SFTSV
vaccine
vesicular stomatitis virus
mutation
assembly
title Two Point Mutations in the Glycoprotein of SFTSV Enhance the Propagation Recombinant Vesicular Stomatitis Virus Vectors at Assembly Step
title_full Two Point Mutations in the Glycoprotein of SFTSV Enhance the Propagation Recombinant Vesicular Stomatitis Virus Vectors at Assembly Step
title_fullStr Two Point Mutations in the Glycoprotein of SFTSV Enhance the Propagation Recombinant Vesicular Stomatitis Virus Vectors at Assembly Step
title_full_unstemmed Two Point Mutations in the Glycoprotein of SFTSV Enhance the Propagation Recombinant Vesicular Stomatitis Virus Vectors at Assembly Step
title_short Two Point Mutations in the Glycoprotein of SFTSV Enhance the Propagation Recombinant Vesicular Stomatitis Virus Vectors at Assembly Step
title_sort two point mutations in the glycoprotein of sftsv enhance the propagation recombinant vesicular stomatitis virus vectors at assembly step
topic SFTSV
vaccine
vesicular stomatitis virus
mutation
assembly
url https://www.mdpi.com/1999-4915/15/3/800
work_keys_str_mv AT qianghu twopointmutationsintheglycoproteinofsftsvenhancethepropagationrecombinantvesicularstomatitisvirusvectorsatassemblystep
AT yuhangzhang twopointmutationsintheglycoproteinofsftsvenhancethepropagationrecombinantvesicularstomatitisvirusvectorsatassemblystep
AT jiafujiang twopointmutationsintheglycoproteinofsftsvenhancethepropagationrecombinantvesicularstomatitisvirusvectorsatassemblystep
AT aihuazheng twopointmutationsintheglycoproteinofsftsvenhancethepropagationrecombinantvesicularstomatitisvirusvectorsatassemblystep